Smaller is better: Eli Lilly is going for more niche drugs

Smaller is better: Eli Lilly is going for more niche drugs

“In other words, Lilly sees its future not in blockbuster medicines like Prozac that are meant for tens of millions of patients, but rather in drugs that are aimed at smaller groups and can be developed more quickly and cheaply, possibly with fewer side effects.”